← Back to Search

Corticosteroid

1-T for Restless Legs Syndrome

N/A
Waitlist Available
Led By Ludwig A Lettau, MD
Research Sponsored by Lowcountry Infectious Diseases
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly during the study and three weeks after treatment completion
Awards & highlights

Study Summary

The purpose of this study is to determine whether, in a randomized, placebo-controlled trial, restless legs syndrome (RLS) can be caused by pinched and damaged foot nerves called neuromas.

Eligible Conditions
  • Restless Legs Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly during the study and three weeks after treatment completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly during the study and three weeks after treatment completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
International Restless Legs Rating Scale

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: 1-TExperimental Treatment1 Intervention
Treatment Group
Group II: 2-PPlacebo Group1 Intervention
Placebo comparator

Find a Location

Who is running the clinical trial?

Lowcountry Infectious DiseasesLead Sponsor
Ludwig A Lettau, MDPrincipal InvestigatorLowcountry Infectious Diseases

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby May 2025